Herein, our study confirmed that SS is a stem cell-derived malignant tumor, and SYT-SSX1 can induce SS cells to participate in EMT transformation as well as enhance the activity of SS stem cells through the TGF-β1/Smad signaling pathway. Here, SS18 is linked to synovial sarcoma.